+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect?



Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect?



Cardiovascular Drugs and Therapy 23(6): 471-480



High cholesterol content of erythrocyte membranes (CEM) levels is present in patients with acute coronary syndromes (ACS). Intraplaque hemorrhage and erythrocyte lysis contribute to the deposition of cholesterol on the atherosclerotic plaque and to plaque rupture. With the present study we assessed the effect of statin therapy on CEM levels, a novel marker of coronary artery disease (CAD) instability during a 1-year follow-up in CAD patients. 212 consecutive eligible (158 men, 62 +/- 10 years) patients undergoing diagnostic coronary angiography for the assessment of angina pectoris were assessed. The study population comprised of 84 chronic stable angina (CSA) patients and 128 ACS patients. All study participants were commenced on statin treatment in equipotent doses and were followed for up to 1 year (at - 1, - 3, - 6 and - 12 months). Repeated measurements analysis of variance after appropriate adjustment showed a significant decrease (p < 0.001) in CEM content during follow up. CEM levels were decreasing at each time point (1 month : 100 microg/mg 95%CI 94.3-105.6, 3 months : 78.1 microg/mg 95%CI 73.2-83, 6 months : 67.2 microg/mg 95%CI 63.1-71.2, 1 year : 45.3 microg/mg 95%CI 42.2-48.3) compared to admission (112.1 microg/mg 95% CI 105.9-118.3) and to all previous measurements. The present study showed, that use of statins is associated with a reduction in CEM, an emerging marker of clinical instability and plaque vulnerability in CAD patients. The pleiotropic effects of statins at the cell membrane level represent a promising novel direction for research in CAD.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911498

Download citation: RISBibTeXText

PMID: 19838647

DOI: 10.1007/s10557-009-6202-7


Related references

Sphingomyelin in erythrocyte membranes increases the total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome. Coronary Artery Disease 24(5): 361-367, 2014

Erythrocyte membranes--effect of increased cholesterol content on permeability. Biochimica et Biophysica Acta 249(2): 647-650, 1971

Effect of lipoprotein spectrum in blood plasma on cholesterol content in erythrocyte membranes. Voprosy Meditsinskoi Khimii: 83-87, 1985

Content of lipids and their fractions in erythrocyte membranes of rats with Guerin's carcinoma, A-avitaminosis and the effect of vitamin A in significant doses. Ukrainskii Biokhimicheskii Zhurnal 51(5): 463-466, 1979

Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin. Upsala Journal of Medical Sciences 117(4): 390-398, 2013

Sphingomyelin content of erythrocyte membranes is in linear association with membranes' loading with cholesterol in coronary artery disease patients. Atherosclerosis 252: E119-E120, 2016

The effect of cholesterol level in erythrocyte membranes on the sedimentation rate, electrophoretic motility, and the rate of potassium ferricyanide reduction. Biofizika 35(2): 293-296, 1990

Changes in the cholesterol content of the erythrocyte membranes in alcoholism. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1988(5): 20-23, 1988

Cholesterol content in erythrocyte membranes in malignant growth. Izvestiya Akademii Nauk Kazakhskoi SSR Seriya Biologicheskaya (5): 78-82, 1989

Erythrocyte membranes compression of lipid phases by increased cholesterol content. Biochimica et Biophysica Acta (BBA) - Biomembranes 274(1): 0-74, 1972

The interaction of the polyene antibiotic lucensomycin with cholesterol in erythrocyte membranes and in model systems. II. Cooperative effects in erythrocyte membranes. Biophysical Journal 13(6): 581-593, 1973

Statin therapy has no significant effect on skin tissue cholesterol: results from a prospective randomized trial. Clinical Chemistry 51(1): 252-254, 2004

Increased cholesterol content of erythrocyte and brain membranes in ethanol-tolerant mice. Biochimica et Biophysica Acta 513(3): 358-363, 1978

Prognostic value of total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 47(4): 305-310, 2019

The replacement of cholesterol by phytosterols and the increase of total sterol content in model erythrocyte membranes. Chemistry and Physics of Lipids 163(7): 689-697, 2010